tiprankstipranks
JB Chemicals & Pharmaceuticals Ltd. (IN:JBCHEPHARM)
:JBCHEPHARM
India Market
Want to see IN:JBCHEPHARM full AI Analyst Report?

JB Chemicals & Pharmaceuticals Ltd. (JBCHEPHARM) Ratios

3 Followers

JB Chemicals & Pharmaceuticals Ltd. Ratios

IN:JBCHEPHARM's free cash flow for Q2 2026 was ₹0.68. For the 2026 fiscal year, IN:JBCHEPHARM's free cash flow was decreased by ₹ and operating cash flow was ₹0.26. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
3.79 3.04 2.13 2.76 3.32
Quick Ratio
2.93 2.20 1.56 1.98 2.25
Cash Ratio
0.14 0.20 0.10 0.14 0.15
Solvency Ratio
1.03 0.99 0.65 0.49 0.98
Operating Cash Flow Ratio
0.54 1.43 0.92 1.13 0.44
Short-Term Operating Cash Flow Coverage
49.51 65.39 2.40 3.79 6.47
Net Current Asset Value
₹ 16.48B₹ 10.82B₹ 7.83B₹ 4.55B₹ 8.06B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.09 0.16 0.02
Debt-to-Equity Ratio
0.01 <0.01 0.13 0.23 0.03
Debt-to-Capital Ratio
0.01 <0.01 0.11 0.19 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 <0.01 0.13 0.00
Financial Leverage Ratio
1.24 1.24 1.37 1.43 1.22
Debt Service Coverage Ratio
71.51 34.35 1.94 2.78 15.28
Interest Coverage Ratio
163.65 79.93 17.01 16.21 115.94
Debt to Market Cap
<0.01 <0.01 0.01 0.04 <0.01
Interest Debt Per Share
2.98 2.43 27.23 39.35 7.57
Net Debt to EBITDA
-0.04 -0.09 0.31 0.70 >-0.01
Profitability Margins
Gross Profit Margin
66.95%65.30%38.63%35.76%64.39%
EBIT Margin
24.54%23.25%22.82%18.95%20.99%
EBITDA Margin
28.87%27.68%26.79%22.60%23.99%
Operating Profit Margin
22.90%22.13%21.65%18.76%18.99%
Pretax Profit Margin
24.43%22.98%21.57%17.82%20.83%
Net Profit Margin
18.22%17.08%15.86%13.15%15.90%
Continuous Operations Profit Margin
18.22%17.08%15.86%13.16%15.92%
Net Income Per EBT
74.58%74.33%73.54%73.81%76.32%
EBT Per EBIT
106.66%103.85%99.65%94.99%109.65%
Return on Assets (ROA)
16.00%15.43%13.84%11.53%14.78%
Return on Equity (ROE)
21.72%19.21%18.90%16.52%18.06%
Return on Capital Employed (ROCE)
23.46%23.47%24.13%19.49%20.71%
Return on Invested Capital (ROIC)
17.42%17.34%15.98%13.60%15.59%
Return on Tangible Assets
22.29%22.75%21.69%18.85%20.51%
Earnings Yield
2.33%2.68%2.10%2.68%3.16%
Efficiency Ratios
Receivables Turnover
4.41 4.28 4.95 5.14 4.05
Payables Turnover
3.34 3.26 5.95 8.45 3.85
Inventory Turnover
2.37 2.53 4.22 4.68 2.11
Fixed Asset Turnover
6.10 5.88 5.49 5.41 4.28
Asset Turnover
0.88 0.90 0.87 0.88 0.93
Working Capital Turnover Ratio
4.40 3.39 3.56 3.34 2.31
Cash Conversion Cycle
127.32 117.40 98.93 105.79 168.47
Days of Sales Outstanding
82.78 85.21 73.78 71.05 90.05
Days of Inventory Outstanding
153.90 144.05 86.45 77.96 173.32
Days of Payables Outstanding
109.37 111.85 61.30 43.22 94.90
Operating Cycle
236.69 229.25 160.23 149.01 263.37
Cash Flow Ratios
Operating Cash Flow Per Share
23.14 56.86 51.67 40.45 22.00
Free Cash Flow Per Share
20.15 50.71 34.80 -9.01 -69.40
CapEx Per Share
2.98 6.15 16.87 49.46 91.41
Free Cash Flow to Operating Cash Flow
0.87 0.89 0.67 -0.22 -3.15
Dividend Paid and CapEx Coverage Ratio
2.32 2.70 1.91 0.70 0.20
Capital Expenditure Coverage Ratio
7.76 9.25 3.06 0.82 0.24
Operating Cash Flow Coverage Ratio
8.86 32.36 2.12 1.09 3.12
Operating Cash Flow to Sales Ratio
0.09 0.23 0.23 0.20 0.07
Free Cash Flow Yield
0.95%3.27%2.05%-0.91%-4.41%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
42.84 37.30 47.54 37.29 31.60
Price-to-Sales (P/S) Ratio
8.00 6.37 7.54 4.90 5.02
Price-to-Book (P/B) Ratio
8.48 7.17 8.99 6.16 5.71
Price-to-Free Cash Flow (P/FCF) Ratio
104.82 30.57 48.72 -109.68 -22.69
Price-to-Operating Cash Flow Ratio
89.09 27.27 32.82 24.43 71.58
Price-to-Earnings Growth (PEG) Ratio
2.51 1.96 1.38 5.92 -2.26
Price-to-Fair Value
8.48 7.17 8.99 6.16 5.71
Enterprise Value Multiple
27.67 22.92 28.46 22.40 20.94
Enterprise Value
330.41B 245.04B 265.62B 157.78B 121.76B
EV to EBITDA
27.67 22.92 28.46 22.40 20.94
EV to Sales
7.99 6.34 7.62 5.06 5.02
EV to Free Cash Flow
104.65 30.45 49.26 -113.23 -22.69
EV to Operating Cash Flow
91.17 27.15 33.18 25.22 71.57
Tangible Book Value Per Share
158.01 129.72 95.35 71.17 182.32
Shareholders’ Equity Per Share
242.94 216.33 188.66 160.38 276.00
Tax and Other Ratios
Effective Tax Rate
0.25 0.26 0.26 0.26 0.24
Revenue Per Share
264.10 243.35 224.86 201.52 313.52
Net Income Per Share
48.12 41.56 35.66 26.50 49.84
Tax Burden
0.75 0.74 0.74 0.74 0.76
Interest Burden
1.00 0.99 0.95 0.94 0.99
Research & Development to Revenue
0.00 0.00 <0.01 0.01 0.01
SG&A to Revenue
0.21 0.24 0.17 0.18 0.18
Stock-Based Compensation to Revenue
0.01 0.01 0.01 0.02 0.03
Income Quality
0.39 1.37 1.45 1.13 0.34
Currency in INR